Terry Brix is listed as an executive officer, director, and promoter on 1 SEC Form D filing by 1 issuer in Mar 2016: S2G Biochemicals Inc. (Vancouver, British Columbia, Canada (as filed: A1) — other technology — 2016).
What this means One deal on file with the SEC, filed Mar 2016. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Chris Sacre (1 shared filing), Colin Armstrong (1 shared filing), Himanshu Kamboj (1 shared filing), Mark Kirby (1 shared filing) and Richard Hopp (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Terry. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Terry Brix and found 2 differences: Terry Brix appears on 1 deal that stopped filing before reaching its target; Same name, different state: "Terry Brix" (OR) is a separate record.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.